IR Med will do a marketing launch, as opposed to a

IR Med will do a marketing launch, as opposed to a product launch later this year. They will not have NASDAQ revs for at least another year imo. They have a super low float. Will they RM with a company that does have those kinds of revs? Time will tell. Sadly many are running out of time. We need a PR that explains new beginnings to allay our fears of another lost year. Let's go....